SKU: C-1260-5mg
PF-06463922 (Lorlatinib) Chemical Formula: C21H19FN6O2 Solid Powder
  • Catalog#: C-1260
  • Targets: ALK
  • Synonym: PF06463922; PF 06463922; PF-06463922; PF-6463922; PF6463922; PF 6463922; Loratinib
  • Chemical Name/IUPAC:(10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile
    Technical Data
  • Product Name: PF-06463922 (Lorlatinib)
  • Chemical Formula: C21H19FN6O2
  • Molecular Weight: 406.41
  • CAS#: 1454846-35-5
  • Appearance: Solid powder
  • Purity: > 99% by HPLC
  • Solubility: Soluble in DMSO
  • Storage: Room temperature for months, or -20ºC for 3 years
    PF-06463922 (Lorlatinib) is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity. Upon administration, ALK/ROS1 inhibitor PF-06463922 binds to and inhibits both ALK and ROS1 kinases. The kinase inhibition leads to disruption of ALK- and ROS1-mediated signaling and eventually inhibits tumor cell growth in ALK- and ROS1-overexpressing tumor cells.